Medical Materiel/Medical Biological Defense Equipment - Eng Dev

Abstract

This program element (PE) funds advanced development of medical materiel within the System Demonstration and Low Rate Initial Production portions of the acquisition life cycle using 6.5 funding. It supports products successfully developed in the Systems Integration portion of the Systems Development and Demonstration phases through completion of the Milestone C Decision Review. Commercially-off-the-shelf (COTS) medical products are also tested and evaluated for military use, when available. This PE primarily includes pivotal (conclusive) human clinical trials necessary for licensure by the Food and Drug Administration. (PROJ 812) project funds military relevant human immunodeficiency virus (HIV) medical countermeasures. These funds provide for engineering and manufacturing development of candidate vaccines and drugs to permit large-scale field testing. Development focused on military unique needs effecting manning, mobilization, and deployment. Products from this project will normally transition to DoD Health Programs or OPA Funds. (PROJ 832) this project funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. Mature commercial-off-the-shelf (COTS) medical products are also evaluated for military use. Consideration will also be given to reduce the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. Products from this project will normally transition to OPA Funds. (PROJ 849) funds development of candidate medical countermeasures for military relevant infectious diseases. These products fall between four major areas: vaccines, drugs, diagnostic kits/devices, and insect control measures to limit exposure and disease transmission. FDA approval is a mandatory obligation for all military products placed into the hands of medical providers or service members for human use. Products from this project will normally transition to DoD Health Programs or OPA funds. (PROJ VS8) program receives products that transition from VS7 and funds effort to complete research and development for the MEDEVAC Mission Essential Packages (MEPs) to support 256 Medical Evacuation legacy helicopters. The force design will increase the number of air frames in the force from 12 to 15 aircraft for 37 MEDEVAC companies to better meet operation needs. This program is managed by U.S. Army Medical Materiel Development Activity (USAMMDA) and U.S. Army Medical Materiel Agency (USAMMA) of the US Army Medical Research and Materiel Command.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2015
Source ID
0604807A_5_2040_PB_2015
Change Summary Explanation
Service Agency Name
Army

Entities

Organizations

  • United States Army

Tags

DTIC Thesaurus Topics

  • Casualties
  • Clinical Trials
  • Combat Casualty Care
  • Combat Support
  • Combat Support Hospitals
  • Contractors
  • Engineering
  • Evacuation
  • Health
  • Health Services
  • Infectious Diseases
  • Medical Evacuation
  • Medical Personnel
  • Military Acquisition
  • Systems Engineering
  • Test And Evaluation
  • Warfare

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Military Science and Technology Research and Modernization.
  • Trauma or Military Medicine

Technology Areas

  • Biotechnology

Related Documents